Key facts
- It has raised $3.1M; the latest was Early Stage VC in May 2025.
- Notable investors include Creative Destruction Lab, Congruent Ventures, Federal Economic Development Agency for Southern Ontario, IP2 Launchpad, Bluestein Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for AuX Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for AuX Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AuX Labs
Operator of a biotechnology company intended to develop alternative protein sources for food and human health. The company combines protein-yielding yeast strains with efficient bioprocesses that utilize low-cost feedstocks in capital-light fermentation facilities to produce nature-identical animal proteins, enabling consumers to avail of alternative proteins at a low price.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2021
- Employees
- 10
- Website
- auxlabs.ca/
- Ownership
- Privately Held (backing)
AuX Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AuX Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AuX Labs in its N-PORT filings yet. We sweep new filings monthly.